RELOVAIR® Lung Deflation Study

Clinical trial NCT01691885 · COMPLETED

Trial details

NCT number: NCT01691885
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2012-11-01
Primary completion: 2014-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.